Pentazocine hydrochloride

This classification denotes an opioid receptor agonist with the molecular formula C19H27NO.ClH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier A36BXO4PPX, chemically known as 2,6-methano-3-benzazocin-8-ol, 1,2,3,4,5,6-hexahydro-6,11-dimethyl-3-(3-methyl-2-butenyl)-, hydrochloride, (2r,6r,11r)-rel- but more generally known as pentazocine hydrochloride, which bears US NIH Compound Identifier 107799. European Medicines Agency schedules Pentazocine hydrochloride in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB03685MIG. Most nations, for tariff and trade purposes, schedule pentazocine hydrochloride under HS 29333300 and SITC 51574. As of Q4 2014, PENTAZOCINE HYDROCHLORIDE remains US FDA's Preferred Term for this commodity. Pentazocine hydrochloride bears US NLM identifiers UMLS ID C0355587 and NCI Concept Code C47661. SMILES: C[C@H]1[C@H]2CC3CCC(CC3[C@@]1(CCN2CC=C(C)C)C)O.CL.